Boya Bio (300294.SZ) plans to establish a company with Chengdu Hengna Shun to enhance the supply capability of raw material plasma.

Chinatimes Financial News App, Boya Biology (300294.SZ) announced that, in order to improve the supply capacity of raw material plasma, enhance market competitiveness, and deepen strategic cooperation with related parties, the company plans to jointly invest in setting up Dalateqi Boya Single Plasma Limited Company with Chengdu Hengnashun Enterprise Management Consulting Co., Ltd. (hereinafter referred to as Chengdu Hengnashun). (The final name is subject to the industrial and commercial registration, hereinafter referred to as the target company).